Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

Go back to Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

Accendra Health, Inc. (ACH) Tops Q1 EPS by 6c, Misses on Revenue; Reaffirms Guidance

May 11, 2026 6:32 AM EDT

Accendra Health, Inc. (NYSE: ACH) reported Q1 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $627.8 million versus the consensus estimate of $646.24 million.

The company is affirming its prior guidance for net revenue and adjusted EBITDA... More